Catalyst Pharmaceuticals, Inc.

Please note: The information displayed on this page might be outdated.
Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, first- or best-in-class medicines for other rare diseases. Catalyst's New Drug Application for FIRDAPSEĀ® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and FIRDAPSE is commercially available in the United States as a treatment for adults with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
Based in...
US - South Atlantic
Clinical Stage
Phase III, Phase l or ll
Disease Space
Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
355 Alhambra Circle
Suite 801
Coral Gables, FL 33134
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Jeff Del Carmen, CCO
  • Mary Coleman, Vice President, Investor Relations
  • Patrick J McEnany, Chairman/President/CEO/Co-Founder
  • Steven Miller, Chief Operating Officer & Chief Scientific Officer

Top 10 Holders of Catalyst Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Armistice Capital LLC 9.92 10,200,000 130.87 13F 6/30/22
State Street Corp. 5.29 5,437,479 69.76 13F 6/30/22
SSgA Funds Management, Inc. 4.90 5,050,989 64.80 Stakes 12/31/21
The Vanguard Group, Inc. 4.69 4,836,313 62.05 Stakes 12/31/21
Vanguard Group, Inc. (Subfiler) 4.50 4,620,792 59.28 13F 6/30/22
LSV Asset Management 3.92 4,029,677 51.70 13F 6/30/22
BlackRock Fund Advisors 3.60 3,695,035 47.41 13F 6/30/22
Millennium Management LLC 2.65 2,723,895 34.95 13F 6/30/22
Dimensional Fund Advisors LP 2.18 2,242,648 28.77 13F 6/30/22
BlackRock Institutional Trust Co. NA 2.15 2,211,767 28.38 13F 6/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.